Keywords: prostatic neoplasms; office management; ERSPC; European Randomized Study of Screening for Prostate Cancer; MRI; magnetic resonance imaging; phi; Prostate Health Index; PSA; prostate specific antigen; PTEN; phosphate and tensin homolog; USPSTF; U.S. Preven